InterCure Stock (NASDAQ:INCR)

Revenue Ownership Financials Chart

Previous Close

$1.97

52W Range

$0.99 - $3.72

50D Avg

$2.15

200D Avg

$2.08

Market Cap

$90.23M

Avg Vol (3M)

$30.18K

Beta

0.06

Div Yield

-

INCR Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

270

IPO Date

Jan 28, 2019

Website

INCR Performance

INCR Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	ILS355.55M	ILS388.68M	ILS219.68M
Operating Income	ILS-40.90M	ILS52.80M	ILS28.19M
Net Income	ILS-61.96M	ILS44.82M	ILS7.30M
EBITDA	ILS-27.74M	ILS64.50M	ILS37.58M
Basic EPS	ILS-1.36	ILS0.99	ILS0.16
Diluted EPS	ILS-1.36	ILS0.99	ILS0.16

Fiscal year ends in Dec 23 | Currency in ILS

Latest Earnings Call Transcripts

Q4 22Apr 04, 23 | 6:56 PM

Q2 22Aug 16, 22 | 2:11 PM

Q1 22May 17, 22 | 5:06 PM

Peer Comparison

Ticker	Company
PAHC	Phibro Animal Health Corporation
RGC	Regencell Bioscience Holdings Limited
IXHL	Incannex Healthcare Limited
SSIC	Silver Spike Investment Corp.
PBH	Prestige Consumer Healthcare Inc.
PCRX	Pacira BioSciences, Inc.
COLL	Collegium Pharmaceutical, Inc.
EGRX	Eagle Pharmaceuticals, Inc.